Literature DB >> 19291144

Management of methicillin-resistant Staphylococcus aureus infections.

J Garau1, E Bouza, J Chastre, F Gudiol, S Harbarth.   

Abstract

This review addresses selected aspects of the management of severe healthcare-associated infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the limitations of current therapy, potential alternative agents, new therapeutic options, clinical approaches to MRSA bacteraemia/endocarditis and ventilator-associated pneumonia, and strategies to improve outcomes in patients with severe MRSA infections.

Entities:  

Mesh：

Year:  2009        PMID： 19291144     DOI： 10.1111/j.1469-0691.2009.02701.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  18 in total

1.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

2.  Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.

Authors:  R A Seaton; S Johal; J E Coia; N Reid; S Cooper; B L Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-31       Impact factor: 3.267

3.  In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Authors:  J M Entenza; T R Veloso; J Vouillamoz; M Giddey; P Majcherczyk; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

4.  Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors:  F Jacobsen; C Fisahn; M Sorkin; I Thiele; T Hirsch; I Stricker; T Klaassen; A Roemer; B Fugmann; L Steinstraesser
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  A high-throughput screen for antibiotic drug discovery.

Authors:  Thomas C Scanlon; Sarah M Dostal; Karl E Griswold
Journal:  Biotechnol Bioeng       Date:  2013-08-29       Impact factor: 4.530

6.  Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.

Authors:  Helio S Sader; Robert K Flamm; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

7.  Assessment of linezolid prescriptions in three French hospitals.

Authors:  C Dentan; E Forestier; M Roustit; S Boisset; S Chanoine; O Epaulard; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-26       Impact factor: 3.267

8.  An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A Therapeutic Challenge.

Authors:  S Sneha; Shanthan Venishetty; Shubha Seshadri; M Sudhakar Rao; Chiranjay Mukhopadhyay
Journal:  J Clin Diagn Res       Date:  2016-12-01

9.  Ciprofloxacin-Loaded Keratin Hydrogels Prevent Pseudomonas aeruginosa Infection and Support Healing in a Porcine Full-Thickness Excisional Wound.

Authors:  Daniel C Roy; Seth Tomblyn; David M Burmeister; Nicole L Wrice; Sandra C Becerra; Luke R Burnett; Justin M Saul; Robert J Christy
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

10.  Soil-Associated Bacillus Species: A Reservoir of Bioactive Compounds with Potential Therapeutic Activity against Human Pathogens.

Authors:  Galal Yahya; Asmaa Ebada; Eman M Khalaf; Basem Mansour; Nehal A Nouh; Rasha A Mosbah; Sameh Saber; Mahmoud Moustafa; Sally Negm; Mohamed M A El-Sokkary; Ahmed M El-Baz
Journal:  Microorganisms       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.